Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryo Cell International (CCEL) Non Operating Investment Income (2019 - 2026)

Cryo Cell International's Non Operating Investment Income history spans 8 years, with the latest figure at -$240458.0 for Q1 2026.

  • Quarterly results put Non Operating Investment Income at -$240458.0 for Q1 2026, down 665.77% from a year ago — trailing twelve months through Feb 2026 was -$1.0 million (down 231.92% YoY), and the annual figure for FY2025 was -$806267.0, down 174.93%.
  • Non Operating Investment Income for Q1 2026 was -$240458.0 at Cryo Cell International, down from -$201648.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $522458.0 in Q3 2024 to a low of -$379332.0 in Q2 2025.
  • The 5-year median for Non Operating Investment Income is -$8642.0 (2022), against an average of $2419.5.
  • The sharpest move saw Non Operating Investment Income plummeted 9473.79% in 2023, then soared 7570.01% in 2024.
  • Year by year, Non Operating Investment Income stood at -$515.0 in 2022, then plummeted by 9473.79% to -$49305.0 in 2023, then surged by 140.56% to $19999.0 in 2024, then plummeted by 1108.29% to -$201648.0 in 2025, then decreased by 19.25% to -$240458.0 in 2026.
  • According to Business Quant data, Non Operating Investment Income over the past three periods came in at -$240458.0, -$201648.0, and -$193886.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.